OXiGENE, Inc. (Nasdaq: OXGN) announced the publication in the peer-reviewed journal Thyroid of the final results of a randomized controlled ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE